{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:07:07Z","timestamp":1793135227137,"version":"4.5.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>We previously showed enteric nerve activation after application of colonic mucosal biopsy supernatants from patients with irritable bowel syndrome (IBS). The question remains whether this is a region-specific or a generalized sensitization. We tested the nerve-activating properties of supernatants from large and small intestinal regions of IBS patients with diarrhea (IBS-D) in comparison to those from mastocytosis patients with diarrhea (MC-D) or non-IBS\/non-MC patients with GI-complaints. MC-D patients were included to test samples from patients with an established, severe mast cell disorder, because mast cells are suggested to play a role in IBS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Voltage-sensitive dye imaging was used to record the effects of mucosal biopsy supernatants from IBS-D, MC-D, and non-IBS\/non-MC on guinea pig submucous neurons. Mast cell density and histamine concentrations were measured in all samples.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median neuroindex (spike frequency \u00d7 % responding neurons in Hz \u00d7 %) was significantly (all <jats:italic>p<\/jats:italic> &amp;lt; 0.001) increased for IBS-D (duodenum and colon, proximal and distal each, 49.3; 50.5; 63.7; 71.9, respectively) compared to non-IBS\/non-MC (duodenum and colon, proximal and distal each, 8.7; 4.9; 6.9; 5.4, respectively) or MC-D supernatants (duodenum and colon, proximal and distal each, 9.4; 11.9; 0.0; 7.9, respectively). Nerve activation by MC-D and non-IBS\/non-MC supernatants was comparable (<jats:italic>p<\/jats:italic>&amp;gt;0.05). Mast cell density or histamine concentrations were not different between IBS-D, MC-D, and non-IBS\/non-MC samples.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Nerve activation by biopsy supernatants is an IBS hallmark that occurs throughout the gut, unrelated to mast cell density or histamine concentration. At least as important is our finding that GI complaints <jats:italic>per se<\/jats:italic> were not associated with biopsy supernatant-induced nerve activation, which further stresses the relevance of altered nerve behavior in IBS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2024.1291554","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T13:52:01Z","timestamp":1719928321000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Biopsy samples from patients with irritable bowel syndrome, but not from those with mastocytosis or unspecific gastrointestinal complaints reveal unique nerve activation in all gut regions independent of mast cell density, histamine content or specific gastrointestinal symptoms"],"prefix":"10.3389","volume":"18","author":[{"given":"Sheila","family":"Vignali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Buhner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Greiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelore","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Frieling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Annahazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","article-title":"Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome","volume":"126","author":"Barbara","year":"2004","journal-title":"Gastroenterology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/j.gastro.2006.11.039","article-title":"Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome","volume":"132","author":"Barbara","year":"2007","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.cgh.2021.04.011","article-title":"Overlap of Rome IV irritable bowel syndrome and functional dyspepsia and effect on natural history: a longitudinal follow-up study","volume":"20","author":"Barberio","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1053\/j.gastro.2017.06.051","article-title":"Vasoactive intestinal polypeptide and mast cells regulate increased passage of colonic bacteria in patients with irritable bowel syndrome","volume":"153","author":"Bednarska","year":"2017","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/ajg.2012.54","article-title":"Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?","volume":"107","author":"Braak","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1113\/jphysiol.2007.139352","article-title":"Histamine excites neurones in the human submucous plexus through activation of H 1, H 2, H 3 and H 4 receptors: histamine excites human enteric neurons","volume":"583","author":"Breunig","year":"2007","journal-title":"J. Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1113\/expphysiol.2014.080036","article-title":"Neuronal activation by mucosal biopsy supernatants from irritable bowel syndrome patients is linked to visceral sensitivity","volume":"99","author":"Buhner","year":"2014","journal-title":"Exp. Physiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0193943","DOI":"10.1371\/journal.pone.0193943","article-title":"Protease signaling through protease activated receptor 1 mediate nerve activation by mucosal supernatants from irritable bowel syndrome but not from ulcerative colitis patients","volume":"13","author":"Buhner","year":"2018","journal-title":"PLoS ONE"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/nmo.12011","article-title":"Submucous rather than myenteric neurons are activated by mucosal biopsy supernatants from irritable bowel syndrome patients: enteric plexuses and IBS supernatants","volume":"24","author":"Buhner","year":"2012","journal-title":"Neurogastroenterol. Motil."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1053\/j.gastro.2009.07.005","article-title":"Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome","volume":"137","author":"Buhner","year":"2009","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12916-022-02301-8","article-title":"Immune responses in the irritable bowel syndromes: time to consider the small intestine","volume":"20","author":"Burns","year":"2022","journal-title":"BMC Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1172\/JCI29255","article-title":"Role for protease activity in visceral pain in irritable bowel syndrome","volume":"117","author":"Cenac","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3892\/etm.2017.4133","article-title":"Role of stem cell growth factor\/c-Kit in the pathogenesis of irritable bowel syndrome","volume":"13","author":"Chai","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1053\/j.gastro.2016.02.032","article-title":"Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3892\/mmr.2013.1320","article-title":"Low-grade inflammation in the rectum of patients with sporadic irritable bowel syndrome","volume":"7","author":"El-Salhy","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/nrdp.2016.14","article-title":"Irritable bowel syndrome","volume":"2","author":"Enck","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1055\/a-1959-3200","article-title":"Endoscopic laser endomicroscopy and \u201cleaky gut\u201d in patients with functional gastrointestinal symptoms and food intolerance","volume":"61","author":"Frieling","year":"2022","journal-title":"Z. Gastroenterol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0029-1245707","article-title":"Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome","volume":"49","author":"Frieling","year":"2011","journal-title":"Z. Gastroenterol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/j.gastro.2014.07.046","article-title":"Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome","volume":"147","author":"Fritscher-Ravens","year":"2014","journal-title":"Gastroenterology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/apt.16591","article-title":"Intestinal chemosensitivity in irritable bowel syndrome associates with small intestinal TRPV channel expression","volume":"54","author":"Grover","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000101711","article-title":"Mastocytosis: state of the art","volume":"74","author":"Horny","year":"2007","journal-title":"Pathobiology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"G1053","DOI":"10.1152\/ajpgi.00153.2011","article-title":"SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine","volume":"302","author":"Kerckhoffs","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1113\/JP271493","article-title":"Neural influences on human intestinal epithelium in vitro: human intestinal secretion","volume":"594","author":"Krueger","year":"2016","journal-title":"J. Physiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1055\/s-0029-1245976","article-title":"S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft f\u00fcr Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft f\u00fcr Neurogastroenterologie und Motilit\u00e4t (DGNM)","volume":"49","author":"Layer","year":"2011","journal-title":"Z. Gastroenterol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00428-022-03423-3","article-title":"The international consensus classification of mastocytosis and related entities","volume":"482","author":"Leguit","year":"2022","journal-title":"Virchows Arch"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1136\/gutjnl-2012-302093","article-title":"Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier","volume":"62","author":"Mart\u00ednez","year":"2013","journal-title":"Gut"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1053\/j.gastro.2005.02.005","article-title":"Serotonin excites neurons in the human submucous plexus via 5-HT3 receptors","volume":"128","author":"Michel","year":"2005","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/jgh.15225","article-title":"Vitamin D receptor is overexpressed in the duodenum of patients with irritable bowel syndrome","volume":"36","author":"Miura","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B29","first-page":"1744","article-title":"Systemische Mastozytose als Grund f\u00fcr chronische gastrointestinale Beschwerden: Praxisorientierte Hinweise zu Diagnostik und Therapie","volume":"102","author":"Molderings","year":"2005","journal-title":"Dtsch. Arztebl."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jaci.2010.12.1113","article-title":"Toward a global classification of mast cell activation diseases","volume":"127","author":"Molderings","year":"2011","journal-title":"J. Aller. Clin. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1046\/j.1365-2982.1999.00163.x","article-title":"Multisite optical recording of excitability in the enteric nervous system","volume":"11","author":"Neunlist","year":"1999","journal-title":"Neurogastroenterol. Motil."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e13070","DOI":"10.1111\/nmo.13070","article-title":"Tryptase potentiates enteric nerve activation by histamine and serotonin: relevance for the effects of mucosal biopsy supernatants from irritable bowel syndrome patients","volume":"29","author":"Ostertag","year":"2017","journal-title":"Neurogastroenterol. Motil."},{"key":"B33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1046\/j.1365-2982.2000.00221.x","article-title":"Increased mast cells in the irritable bowel syndrome","volume":"12","author":"O'Sullivan","year":"2000","journal-title":"Neurogastroenterol. Motil."},{"key":"B34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1440-1746.2005.04143.x","article-title":"Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome","volume":"21","author":"Park","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1136\/gut.2007.127068","article-title":"Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome","volume":"57","author":"Piche","year":"2007","journal-title":"Gut"},{"key":"B36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/002215540305100510","article-title":"An antibody raised against in vitro-derived human mast cells identifies mature mast cells and a population of cells that are Fc epsilon RI(+), tryptase(-), and chymase(-) in a variety of human tissues","volume":"51","author":"Qi","year":"2003","journal-title":"J. Histochem. Cytochem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/MPG.0000000000003588","article-title":"Identifying mast cells in gastrointestinal biopsies in pediatric irritable bowel patients","volume":"75","author":"Rizvi","year":"2022","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e13718","DOI":"10.1111\/nmo.13718","article-title":"Mast cells are increased in the small intestinal mucosa of patients with irritable bowel syndrome: a systematic review and meta-analysis","volume":"31","author":"Robles","year":"2019","journal-title":"Neurogastroenterol. Motility"},{"key":"B39","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1053\/j.gastro.2013.01.040","article-title":"Functions and imaging of mast cell and neural axis of the gut","volume":"144","author":"Schemann","year":"2013","journal-title":"Gastroenterology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2982.2004.00591.x","article-title":"Human mast cell mediator cocktail excites neurons in human and guinea-pig enteric nervous system","volume":"17","author":"Schemann","year":"2005","journal-title":"Neurogastroenterol. Motil."},{"key":"B41","doi-asserted-by":"publisher","first-page":"G919","DOI":"10.1152\/ajpgi.00043.2002","article-title":"III. Imaging and the gastrointestinal tract: mapping the human enteric nervous system","volume":"282","author":"Schemann","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3109\/00365521.2013.857712","article-title":"Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea","volume":"49","author":"Sohn","year":"2013","journal-title":"Scand. J. Gastroenterol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/gut.47.6.804","article-title":"Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome","volume":"47","author":"Spiller","year":"2000","journal-title":"Gut"},{"key":"B44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1600-065X.2007.00519.x","article-title":"Differential release of mast cell mediators and the pathogenesis of inflammation","volume":"217","author":"Theoharides","year":"2007","journal-title":"Immunol. Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/MEG.0000000000001737","article-title":"Clinical efficacy and safety of ketotifen in treating irritable bowel syndrome with diarrhea","volume":"32","author":"Wang","year":"2020","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.3748\/wjg.v13.45.6041","article-title":"Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome","volume":"13","author":"Wang","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10620-020-06264-9","article-title":"Mast cell activation syndrome: a primer for the gastroenterologist","volume":"66","author":"Weinstock","year":"2021","journal-title":"Dig. Dis. Sci."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2024.1291554\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T13:52:06Z","timestamp":1719928326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2024.1291554\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":48,"alternative-id":["10.3389\/fnins.2024.1291554"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2024.1291554","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,2]]},"article-number":"1291554"}}